Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2026-01-27 @ 8:27 AM
Study NCT ID:
NCT01083160
Status:
TERMINATED
Last Update Posted:
2012-01-19
First Post:
2010-02-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use
Sponsor:
Abbott
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
P10-604
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None